Anthropic's debut will break the daily reset

Anthropic's debut, if it lands anywhere near the $1 trillion mark its filing implies, will be both a verdict on the AI company's valuation and a stress test for a corner of the ETF market that has built its product on a simple promise: a leveraged multiple of a stock's daily move, reset every session against the prior close. On day one, there is no prior close.

A leveraged single-stock ETF is less a buy-and-hold expression of a long-term view than a daily claim, engineered to deliver a fixed multiple of the underlying security's return from one close to the next. Its managers do not hold a static position and let it ride; they rebalance exposure at the end of each trading day so the next begins with the promised leverage intact. That daily reset is the product, and on day one it is its vulnerability.

The arithmetic is unforgiving: to compute what a 2x or 3x return means for any given session, the fund needs a base price from the immediately preceding session, the denominator against which that day's move is measured. An IPO has no such denominator, and Anthropic's shares will open for the first time without a single historical closing print. The offering price exists, but it is not a close; it is an auction-clearing construct set before the market ever has a chance to trade the stock. The first actual trade may gap far from it, and the first close may be something else again. Which of those numbers becomes the reference for a leveraged product that lists the same morning is not a matter of market convention; it is a decision no rulebook has yet forced anyone to make.

The most obvious fallback is to treat the IPO price as the synthetic prior close, likely what an engineer would choose since it is the only official price that exists before the opening auction, and that choice has consequences. If Anthropic's first trade prints ten percent above the offering price, a two-times fund using the offering price as its base would treat that opening gap as a daily return of ten percent and call for a twenty percent gain before the stock has traded a single share in the aftermarket. The fund cannot create that gain instantly; it must acquire exposure at the market price, which has already moved, and the daily reset math, built on a smooth handoff from one close to the next, has been asked to digest a gap.

If instead the fund waits until the first close to establish its reference price, it has effectively admitted that the product cannot run on day one, and even that wait solves only part of the problem. The first close is a single observation, not a price series, and although volatility runs high on debut days, the daily reset mechanic assumes that volatility is the very thing the product monetizes. The fund can rebalance against that first close and the math will work in a mechanical sense, but no one can tell investors whether that first close is a stable equilibrium or an artifact of an order book that has not yet found its level. A leveraged product built on that number is rebalancing against a data point rather than a market.

Authorized participants and market makers rely on reference prices to hedge exposure: on a normal day, the prior close gives them a starting point for the underlying and the fund's net asset value, but on an IPO morning the only reference before the open is the offering price and the only reference after the open is a moving market. A market maker trying to quote a leveraged ETF in that window is trying to make a two-sided market in a product whose daily return denominator is still being negotiated, and the same absence that complicates the fund's rebalancing also complicates the bid-ask spread. That may be why no issuer has yet announced a product, and why the test will be live the moment one does.

The scale of the Anthropic event compounds the problem: a one percent move in a trillion-dollar company is ten billion dollars of market capitalization changing hands. Leveraged single-stock products are typically designed for traders who want to magnify daily moves without holding margin, and on a debut day the underlying stock's move can be several times larger than a normal session, which is presumably why issuers would want product on the tape early. The same volatility that creates that demand also breaks the instrument's core assumption, because a daily reset is a poor tool for an intraday dislocation.

A leveraged single-stock product's disclosures are written around a security with an established closing-price series, and an IPO has none, so the disclosure cannot describe the very first rebalance with the same specificity that it brings to a company with months of trading behind it. The prospectus can warn about daily compounding and the risk of holding longer than one day, but it cannot tell an investor what the fund will do when the denominator itself is missing. That is a category boundary rather than a regulatory failure, and the product was built for day two, not day one.

Consider the sequence if a fund does list on day one: the offering price is set by the underwriting syndicate, the stock opens for trading with its first true market price, and the fund's net asset value at that moment is based on whatever reference the issuer chose. If the fund uses the offering price, the opening print is a return; if it uses the opening print, the first intraday move is a return. Either way, the fund enters a day of unprecedented volatility with a leverage multiple that must be reset at the close, and that reset will require buying or selling exposure at the closing auction—the exact moment when the entire market is trying to figure out where the stock settles. That is a feature in a normal product and a bug in this one, because the price being settled has no history to anchor it.

The right response is not to list on day one. Demand for leveraged exposure to a hot debut is real, but the product's mechanics cannot be made faithful to its promise until at least one full session closes, and issuers that rush to file and list before a stable price series forms are solving a distribution problem with an instrument built for a trading problem. They will be selling a daily reset against a phantom close, with the gap between the offering price and the first close flowing straight into performance that no one can predict, a risk the issuer understands but the investor who buys the fund for a two-hour hold may not.

Anthropic's listing will generate enormous volume and attention, and the first trade will be reported as a verdict on its valuation while the first close will be reported as a verdict on the day. The more consequential question for the ETF complex is narrower: whether any leveraged product lists before the first close has settled into a data point that a daily reset can actually use. If one does, the debut will test whether the daily rebalancing promise can survive its first morning.